These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Diagnosis and the current trends in multiple myeloma therapy. Dmoszyńska A Pol Arch Med Wewn; 2008 Oct; 118(10):563-6. PubMed ID: 19112817 [TBL] [Abstract][Full Text] [Related]
6. Thalidomide, lenalidomide and bortezomib in the management of newly diagnosed multiple myeloma. Laubach JP; Schlossman RL; Mitsiades CS; Anderson KC; Richardson PG Expert Rev Hematol; 2011 Feb; 4(1):51-60. PubMed ID: 21322778 [TBL] [Abstract][Full Text] [Related]
7. New drugs for myeloma. Richardson PG; Mitsiades C; Schlossman R; Munshi N; Anderson K Oncologist; 2007 Jun; 12(6):664-89. PubMed ID: 17602058 [TBL] [Abstract][Full Text] [Related]
8. Evolving role of novel agents for maintenance therapy in myeloma. Magarotto V; Palumbo A Cancer J; 2009; 15(6):494-501. PubMed ID: 20010169 [TBL] [Abstract][Full Text] [Related]
9. New treatments for myeloma. Azaïs I; Brault R; Debiais F Joint Bone Spine; 2010 Jan; 77(1):20-6. PubMed ID: 20031467 [TBL] [Abstract][Full Text] [Related]
11. Bortezomib: a valuable new antineoplastic strategy in multiple myeloma. Bladé J; Cibeira MT; Rosiñol L Acta Oncol; 2005; 44(5):440-8. PubMed ID: 16118077 [TBL] [Abstract][Full Text] [Related]
12. Tandem transplants in the treatment of multiple myeloma. Pro. Fassas AB; Tricot G Clin Adv Hematol Oncol; 2004 May; 2(5):303-4. PubMed ID: 17682284 [No Abstract] [Full Text] [Related]
13. Advances in the treatment of multiple myeloma: a nursing perspective. Barrick M ONS News; 2006; 21(8 Suppl):15-6. PubMed ID: 16925133 [No Abstract] [Full Text] [Related]
14. Clinical updates and nursing considerations for patients with multiple myeloma. Faiman B Clin J Oncol Nurs; 2007 Dec; 11(6):831-40. PubMed ID: 18063542 [TBL] [Abstract][Full Text] [Related]
15. New developments in the treatment of patients with multiple myeloma. Minnema MC; van der Spek E; van de Donk NW; Lokhorst HM Neth J Med; 2010 Jan; 68(1):24-32. PubMed ID: 20103818 [TBL] [Abstract][Full Text] [Related]
16. Overview of drug therapy for multiple myeloma. Saunders G J Oncol Pharm Pract; 2005 Sep; 11(3):83-100. PubMed ID: 16390597 [TBL] [Abstract][Full Text] [Related]
17. The emerging role of novel therapies for the treatment of relapsed myeloma. Richardson PG; Hideshima T; Mitsiades C; Anderson KC J Natl Compr Canc Netw; 2007 Feb; 5(2):149-62. PubMed ID: 17335684 [TBL] [Abstract][Full Text] [Related]
18. Treatment paradigms for the newly diagnosed patient with multiple myeloma. Greipp P Semin Hematol; 2005 Oct; 42(4 Suppl 4):S16-21. PubMed ID: 16344097 [TBL] [Abstract][Full Text] [Related]
19. New treatments for multiple myeloma. Richardson PG; Schlossman R; Hideshima T; Anderson KC Oncology (Williston Park); 2005 Dec; 19(14):1781-92; discussion 1792, 1795-7. PubMed ID: 16506632 [TBL] [Abstract][Full Text] [Related]
20. Current status of new drugs for the treatment of patients with multiple myeloma. Kenealy M; Prince HM Intern Med J; 2006 Dec; 36(12):781-9. PubMed ID: 17096741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]